MINISTRY OF HEALTH Cervical Cancer in Kenya Presentation to the Cancer workshop – KNH 13 th April 2012 Dr Nancy Kidula.

Slides:



Advertisements
Similar presentations
REDUCING MATERNAL AND NEONATAL MORTALITY IN MOZAMBIQUE THE CHALLENGE IN THE NEW MILLENIUM.
Advertisements

Harshad Sanghvi Medical Director, JHPIEGO
Integration: Intersection for Reproductive Health and HIV Programs: the Kenyan Experience Family Health International Sponsored Satellite Session World.
EFFORTS TO PREVENT MATERNAL AND NEWBORN MORBIDITY AND MORTALITY IN KISARAWE DR. M.O. KISANGA KISARAWE INTRODUCTION Kisarawe District is among the seven.
Towards an AIDS-Free Generation Women & Girls and HIV in PEPFAR
Cervical Screening and HPV testing
MANAGEMENT OF THE ABNORMAL PAP SMEAR
National Conference on MDG 5 – Improving Maternal Health in Pakistan November, 2013 Islamabad, Pakistan.
Adolescents and HIV Alison Jenkins, UNICEF Tanzania Cover photo: © Khanga Rue Media/2014/Olvera.
Somaiya Medical College and Maina Foundation Five Year Project for Raising breast Cancer Awareness in Pratikshanagar - Mumbai.
MS&E 220 Project Yuan Xiang Chew, Elizabeth A Hastings, Morris Jinhui Zhang Probabilistic Analysis of Cervical Cancer Screening and Vaccination.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Inclusion of Adolescents with Disabilities: Towards an AIDS-Free Generation All In! Rosangela Berman Bieler Senior Adviser, Children with Disabilities,
Spotlight on Cervical Cancer Screening
The HPV Vaccine: Protecting Girls from Cervical Cancer
Preventive Care and Sexual Health Information for Tweens and Teens
Cancer Prevention in Taiwan
Early Childhood Development HIV/AIDS in Malawi
Cervical Cancer and Women Living with HIV: A Call to Action Sethembiso Promise Mthembu ICWSA
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Departmental Perspectives on Viral Hepatitis
HPV & Cervical Cancer Frequently Asked Questions HPV & Cervical Cancer Prevention 2009 International Toolkit.
1 CHILDREN AFFECTED BY HIV/AIDS : Botswana Experience BY MINISTER OF HEALTH BOTSWANA HON. PROF. SHEILA DINOTSHE TLOU DATE 29 NOVEMBER 2007 IRELAND.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Integration of postnatal care with PMTCT: Experiences from Swaziland
Scaling-up Cervical Cancer Prevention Program in Mozambique Republic of Mozambique Addis Ababa -October, 2013 Ministry of Health.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Cancer Care Ontario A Organizational Overview S Orientation Workshop July 16, 2014 Sheila M Densham, BA, TEACH Health Promotion Coordinator.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
HPV VACCINATION Dr Frida Mghamba 2 nd East Africa WE CAN Summit 11 th September 2014.
OUTCOME OF CONDUCTING OUTREACHES IN CERVICAL CANCER SCREENING AT OL-JORO OROK SUB-COUNTY IN NYANDARUA COUNTY KENYA Lydiah Ndegwa, Danson Macharia, Osbon.
The HPV Vaccine: Protecting Your Daughter from Cervical Cancer Your questions deserve trusted answers.
May Maloba, CCSP Coordinator August 10,  FACES CCSP overview  Program emphasis  Screening protocols  M & E  Achievements  Challenges.
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
HPV and Cervical Cancer FAQ. What is cervical cancer? Cervical cancer is cancer of the cervix, the part of the uterus or womb that opens to the vagina.
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
Integration of HIV/AIDS and Cervical Cancer Programs for Improved Health Outcomes in Tanzania Dr. January Zilabumba IMA World Health 30 November, 2015.
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
1 April 2010 Jhpiego/Baltimore Veronica Reis, MD, MPH MCHIP Technical Director MAPUTO, MOZAMBIQUE BREAST AND CERVICAL CANCER PREVENTION ACTIVITIES INTEGRATED.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
By: Maria Jorgensen. Uganda has a high maternal mortality ratio, typical of many countries in sub-Saharan Africa, with an estimated 505 maternal deaths.
Division of Reproductive Health Scaling up cervical cancer prevention and treatment in Kenya DR Nakato Jumba DRH CERVICAL CANCER PARTNER FORUM, ELDORET.
Mary Rose Giattas Marya Plotkin Giulia Besana Maryjane Lacoste Safina Yuma Robert Kamala Mainza Lukobo-Durrell Megan Wysong Harris Sharon Kibwana Kelly.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
2014 Kenya Demographic and Health Survey (KDHS) Key Indicators.
Cervical Cancer How We Can Prevent It Dr Quek Swee Chong Himalayan Women’s Health Project 30 August 2014.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
CANCER OF THE CERVIX SCREENING AND EARLY TREATMENT Dr Nelly R. Mugo MBchB, MMED, MPH Dr Rose J. Kosgei MBchB, MMED, Msc Kenyatta National Hospital: Department.
The summary of preventive examinations- cervical cancer Agnieszka Wrzesińska, MD Project entitled „ Equal in health – prevention and early detection of.
Dr. Farhat R Malik Assistant Professor Community Health Sciences.
1Management Sciences for Health Stronger health systems. Greater health impact. 16 th ICASA Conference – Addis Ababa, 4 th - 8 th December 2011 Author;
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
INITIATIVES OF HIGH LEVEL TASKFORCE FOR WOMEN, GIRLS, GENDER EQUALITY AND HIV FOR EASTERN AND SOUTHERN AFRICA TACAIDS.
#AIDS2016 Cervical Cancer Prevention in Africa: The Future Nelly Yatich, DrPH University of California San Francisco July 19 th, 2016.
Planning and Implementing Cervical Cancer Programs
INTRODUCTION: CERVICAL CANCER SCREENING
Treatment Options for Cervical Cancer in Low Income Countries
World Health Organization
Ontario Colposcopy Clinical Guidance 2016
Introduction Acknowledgments Identified need Project objective
528,000 new cases 266,000 death 90 % of the deaths in LMIC
The National Cervical Screening Programme
Cervical Screening Programme
SEXUALLY TRANSMITTED INFECTIONS (STIs) PREVENTION & CARE
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

MINISTRY OF HEALTH Cervical Cancer in Kenya Presentation to the Cancer workshop – KNH 13 th April 2012 Dr Nancy Kidula

MINISTRY OF HEALTH WHY FOCUS ON CERVICAL CANCER? Second most common cancer in Women worldwide, currently affecting over 1 million women Leading cause of death from cancer among women in developing countries Over 90% of cases are in developing countries

MINISTRY OF HEALTH Global maternal mortality estimates (MMR)

MINISTRY OF HEALTH ~270,000 deaths annually; 88% in low-resource areas 2011 CCA REPORT CARD

MINISTRY OF HEALTH Slide 5 Adolescent pregnancies - Mothers too soon: In Bangladesh, 65 percent of 20- to 24-year-old women were married before the age of 18. (source UNICEF). Adolescent girls and young women are at high risk of contracting sexually transmitted diseases or HIV. In Malawi and Ghana, around one third of girls reported that they were “not willing at all” at their first sexual experience.

MINISTRY OF HEALTH Comparison with Maternal Mortality 2011 CCA REPORT CARD

MINISTRY OF HEALTH Cervical Cancer and HIV/AIDs

MINISTRY OF HEALTH LIMITED ACCESS TO A HEAVY BURDEN

MINISTRY OF HEALTH 2011 CCA REPORT CARD

MINISTRY OF HEALTH 2011 CCA REPORT CARD

MINISTRY OF HEALTH WHAT DOES THIS GRAPH TELL US ?

MINISTRY OF HEALTH Cervical Cancer: sub-Saharan Africa (Anorlu. Reprod Health Matters 2008;16:41)  22% of all cancers in women (IARC 2003)  Survival rate (2002) 21% vs 70% in US (Ca 2005;55:74)  Important factors:  Endemic HPV  High rates of HIV  Unavailability/inaccessibility of cytology-based screening: poor health infrastructure, limited human capacity, cost  Loss to follow-up: poverty, residence far from health centers, lack of effective mechanisms for recall of women with abnormal paps (60-80% default among those with cytologic abnormalities-Cronje 2004)

MINISTRY OF HEALTH Cervical Cancer: sub-Saharan Africa (Anorlu. Reprod Health Matters 2008;16:41) Lack of effective treatment resources: surgical expertise, radiotherapy (2003: 15 African countries did not have RT capacity-Ashraf. Lancet 2003;361:2209) Inadequate palliative care: most pts present in late stages: only 11/47 African countries use morphine for chronic pain (Harding. Lancet 2005;365:1971)

MINISTRY OF HEALTH Kenya situation

MINISTRY OF HEALTH Women at risk for cervical cancer (over 15yrs) million 15

MINISTRY OF HEALTH Kenya statistics Annual number of cervical cancer cases Annual number of cervical cancer deaths-1676 Projected new Ca cervix cases in Coverage of Cervical cancer screening for all women yrs- 3.2%

MINISTRY OF HEALTH

Kenya statistics ctd Prevalence of abnormal cytology in general population - 3.6% Prevalence of abnormal cytology in HIV positive women – much higher HPV 16 and 18 prevalence in women with HGSIL- 60.9%

MINISTRY OF HEALTH

The Kenya Situation- Screening Currently over 100 sites are regularly screening across the country Screening Methods: cytology- pap smear, VIA/VILI HPV testing – mainly in research and private sector 20

MINISTRY OF HEALTH Kenya situation- Treatment Treatment of dysplasia available in only 30% of screening sites Hence In many cases patients with dysplasia are over treated or not treated at all ( e.g. TAH for CIN 1!!) About 100 sites now offer cryotherapy equipment for treatment of dysplasia

MINISTRY OF HEALTH Kenya situation:- Cancer Average age at presentation for invasive cancer is 42 years In most cases it is diagnosed late (>90% are stage IIB or worse) KNH is the only national hospital with radiotherapy Several regional hospices offer Palliative care

MINISTRY OF HEALTH Overview of the National Cervical Cancer Strategic Plan

MINISTRY OF HEALTH NCCPP Vision Kenyan women free from cervical cancer Goal: To reduce incidence, prevalence, morbidity and mortality from cervical cancer and improve quality of life of cervical cancer patients in accordance to the Health policy framework, the National RH policy and National RH strategy.

MINISTRY OF HEALTH Objectives: To create an enabling environment for expansion of the National Cervical Cancer Program To create demand for cervical cancer prevention and control services. To provide high quality cervical cancer prevention and treatment services. To strengthen referral system for the cervical cancer program (linkages)

MINISTRY OF HEALTH Components of cervical cancer control Primary prevention Early detection / screening Diagnosis and treatment Palliative care

MINISTRY OF HEALTH Primary prevention strategies The following Primary prevention strategies are advocated for use in Kenya –Promote Abstinence or delayed sexual debut for adolescents (A) –Promote faithfulness to one partner for those in relationships, (B) –Promote Condom use - C –Promote HPV Vaccination –Promote male circumcision

MINISTRY OF HEALTH HPV vaccination The target for vaccination will be Pre and young adolescent girls before first coitus. The recommended age group is 9-13 years. Either bivalent or quadrivalent type of vaccine may be used Out of school population will be targeted through facility or outreach approach No boosters will be given The roll out of this programme will be led by the Division of Vaccine and immunization

MINISTRY OF HEALTH 29 VMMC The Kenyan program has provided VMMC services to more than 400,000 clients, reaching more men and boys than any other national program. Nyanza province contributes more than 80% of the effort but implementation is also in Teso, Turkana and Nairobi

MINISTRY OF HEALTH Screening Approaches The following screening approaches are recommended for public health use in Kenya –VIA/VILI, –Pap smear cytology –HPV testing Other screening approaches may be used for research or teaching purposes

MINISTRY OF HEALTH Target Population For screening to be cost effective, women in the high-risk age group have to be targeted. The recommended target group is women years (Women outside this group who wish for screening or for whom screening is advisable will not be denied services) The recommended screening interval is 5 years for HIV negative women

MINISTRY OF HEALTH Entry Points for screening Cervical Cancer Screening will be provided as an Integrated service at all KEPH levels The recommended initial entry points for cervical cancer screening are: –the MCH/FP clinics, –the Comprehensive Care Clinics and –the Gynecology clinic. Cervical cancer screening will also be integrated into other RH outreach activities e.g. during integrated RH/FP camps, and campaigns in order to reach more women especially in hard to reach areas.

MINISTRY OF HEALTH Screening in HIV positive women All HIV positive women with history of sexual activity years old will be screened for cervical cancer The screening cycle for HIV will be as follows: –- At diagnosis –-6 monthly in the 1 st year –-Then yearly if normal

MINISTRY OF HEALTH Screening during pregnancy Screening will be offered to women in pregnancy until 20 weeks gestation. No treatment will be offered in pregnancy unless there is evidence of a malignant lesion. If cervical dysplasia is noticed, the woman will be advised to return at weeks post partum for re-screening and treatment. Eligible women will also be offered screening at 6 weeks postpartum

MINISTRY OF HEALTH Treatment of Pre- cancer The following are the recommended treatment strategies for precancerous lesions for the Kenya program: –Cryotherapy –Loop Electrosurgical Excision Procedure (LEEP) –Cold knife Conization

MINISTRY OF HEALTH Treatment approaches The specific treatment of precancerous lesions will depends on the severity, size, and location of the lesion The program recommends availability of cryotherapy from KEPH level 3. The programme recommends availability of LEEP at level 5 and above As far as possible the Single Visit Approach should be employed

MINISTRY OF HEALTH Providers of treatment services It is recommended that Cryotherapy at district hospitals and below be done by appropriately trained non-physicians (nurses, Clinical Officers & doctors) provided they are competent in the procedure

MINISTRY OF HEALTH Treatment of advanced disease Only gynecologists should do LEEP; it should be done at provincial or referral hospitals Gynecologists should do cancer diagnosis and staging at provincial and referral hospitals Palliative care is an integral part of the programme and should be strengthened at all levels

MINISTRY OF HEALTH Data management A basic set of standardised data tools will be introduced to facilitate data management. These include: Cervical cancer screening form A daily register A monthly summary tool A data use poster A support supervision tool Key indicators will also be incorporated into the routine HIS data capturing tools i.e. Mother Child booklet and the Longitudinal registers.

MINISTRY OF HEALTH A team approach to cervical cancer Prevention and control Cervical cancer control requires a multi- sectoral and multidisciplinary effort. It also requires strong linkages and team work between providers at all levels of Health care system

MINISTRY OF HEALTH Conclusion Cervical Cancer is a major public health concern in Kenya due to its prevalence, morbidity and mortality Overt cancer is expensive to treat Investing in cervical cancer prevention and control saves lives, improves the quality of the woman’s life and is cost saving to the country